Involving Peroxidase Patents (Class 435/28)
-
Patent number: 8883436Abstract: Enzymes and/or polypeptides and/or mixtures of interest are evaluated during hydrolysis of cellulosic material by the use of indicator constituents such as fluorescent agents, resulting in efficient high-throughput analysis of enzymes and/or polypeptides. A high-throughput assay for the analysis of inter alia, pretreated corn stover (PCS) hydrolysis is also disclosed.Type: GrantFiled: July 13, 2010Date of Patent: November 11, 2014Assignee: Novozymes A/SInventors: Marco Malten, Keith McFarland
-
Publication number: 20140329258Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.Type: ApplicationFiled: July 15, 2014Publication date: November 6, 2014Inventor: Roger Fleming
-
Patent number: 8852953Abstract: The invention relates to novel immunogens, antibodies, methods and kits for use in immunoassays to detect and quantify zaleplon, metabolites of zaleplon and indiplon. These are the first described immunoassays for these compounds and have greater sensitivity than alternative analytical techniques.Type: GrantFiled: July 16, 2010Date of Patent: October 7, 2014Assignee: Randox Laboratories Ltd.Inventors: Elouard Benchikh, Stephen Peter Fitzgerald, Philip Andrew Lowry, Ivan Robert McConnell
-
Publication number: 20140273055Abstract: A noninvasive method for diagnosing skin health in a subject comprising collecting a skin sample/epithelial cell sample from the subject; detecting a level of one or more biomarkers selected from the group consisting of Myeloperoxidase and oxidized lipids in the epithelial cell sample/skin cell sample; diagnosing the subject as having oxidative stress and/or oxidative damage based on the level of a detected biomarker. Further, a noninvasive method for evaluating the efficacy of products for skin health.Type: ApplicationFiled: March 14, 2014Publication date: September 18, 2014Applicant: The Procter & Gamble CompanyInventors: Kathleen Marie KERR, Angela Marie FIENO, Kenneth Robert WEHMEYER, Lijuan LI, James Robert SCHWARTZ, Raymond Alan GRANT
-
Patent number: 8834878Abstract: A method for the treatment of cancer is provided wherein a cancer recognition (CARE) antigen or CARE antibody is administered to a patient. Administration of the CARE antigen or antibody will induce an immune or promote a response of IgM CARE antibodies which will bind to CARE antigen bound to cancer cells, inducing an immune response to destroy the cancer cells. Subsequent to said treatment, ELISA assays may be used to detect levels of said CARE antigen to monitor the efficacy of the treatment, and to govern the further administration of CARE antigens.Type: GrantFiled: June 6, 2007Date of Patent: September 16, 2014Inventor: Jerry T. Thornthwaite
-
Patent number: 8822168Abstract: The present invention includes assays and kits for detecting the assembly of an RNA binding protein-RNA complex and for detecting the activity of an RNA binding protein.Type: GrantFiled: March 10, 2006Date of Patent: September 2, 2014Assignee: The Trustees of the University of PennsylvaniaInventors: Gideon Dreyfuss, Lili Wan, Elizabeth Ottinger
-
Patent number: 8815532Abstract: Provided herein are novel reagents and their use in color-producing detection systems for performing diagnostic tests and analytical assays.Type: GrantFiled: May 23, 2012Date of Patent: August 26, 2014Assignee: Diagnostic Innovations, LLCInventor: Victor Kovalenko
-
Publication number: 20140234874Abstract: The invention provides compositions, kits, and methods for performing colorimetric analysis. A substrate is reacted to generate a chromogenic reaction product, and a reaction stop reagent that is a sulfonic acid is added to stop and stabilize the reaction product. The absorbance properties of the chromogenic reaction product can be maintained over significantly longer periods of time of that of conventional reagents and methods. The sulfonic acid can be used in assays such as ELISAs in order to provide a more accurate and safer detection of analytes in a biological sample.Type: ApplicationFiled: April 30, 2014Publication date: August 21, 2014Applicant: SurModics, Inc.Inventors: Gary Opperman, Wendy Nelson
-
Publication number: 20140220612Abstract: The invention provides novel fluorinated resorufin compounds that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats.Type: ApplicationFiled: April 8, 2014Publication date: August 7, 2014Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Robert BATCHELOR, Yue GE, Iain JOHNSON, Wai-Yee LEUNG, Jixiang LIU, Brian PATCH, Peter SMALLEY, Thomas STEINBERG, Kyle GEE
-
Patent number: 8795646Abstract: The present application relates generally to oral pharmaceutical formulations for the treatment of human canities.Type: GrantFiled: September 7, 2012Date of Patent: August 5, 2014Inventor: Garfield Coore
-
Publication number: 20140212895Abstract: The invention provides for detecting target subpopulations of cells that have high proliferative and renewal properties in animals, including circulating tumor cells, cancer stem cells, hematopoietic stem cells and endothelial progenitor cells. The invention utilizes a defined substrate and media of known property to enrich target cell subpopulations which can be used for future genetic, proteomic and morphological analyses. The method can use image-capture and analysis software to characterize cells based on physical properties, such as size, morphology and kinetic properties.Type: ApplicationFiled: January 24, 2014Publication date: July 31, 2014Applicant: Xcell Biosciences, Inc.Inventor: James Lim
-
Publication number: 20140206013Abstract: An imaging method utilizing a split peroxidase is described herein. Imaging methods involve contacting a cell with a split peroxidase and a substrate thereof to allow conversion of a substrate into a product via an enzymatic reaction catalyzed by the reconstitute split peroxidase. Also disclosed herein are split peroxidases, related products and kits.Type: ApplicationFiled: January 16, 2014Publication date: July 24, 2014Applicant: Massachusetts Institute of TechnologyInventors: Alice Y. Ting, Jeffrey Daniel Martell
-
Patent number: 8778688Abstract: Described herein are high-throughput methods of monitoring D-serine levels in plasma. The assay involves the use of strong cation solid phase extraction (SPE) to isolate D-serine from plasma, followed by quantitation of D-serine using the D-amino acid oxidase- (DAAO-) catalyzed reaction. Also described are methods of screening for compounds that act as DAAO inhibitors.Type: GrantFiled: November 8, 2012Date of Patent: July 15, 2014Assignee: The Johns Hopkins UniversityInventors: Barbara S. Slusher, Jesse Alt, Camilo Rojas, Takashi Tsukamoto
-
Publication number: 20140193847Abstract: [Problem] To provide a novel isotope-labeled compound that can be used as a trapping agent and that is useful for picking out drug-candidate compounds that produce reactive metabolites. [Solution] Provided is a glutathione alkylester isotopologue represented by general formula (1). In formula (1), R1 represents a linear or branched alkoxy group in which at least one of carbon, oxygen, and hydrogen atoms contained therein is isotope-labeled and which has 1 to 8 carbon atoms or a cycloalkoxy group in which at least one of carbon, oxygen, and hydrogen atoms contained therein is isotope-labeled and which has 3 to 8 carbon atoms.Type: ApplicationFiled: May 21, 2012Publication date: July 10, 2014Applicant: Kyorin Pharmaceutical Co., LtdInventor: Toshikazu Yamaoka
-
Publication number: 20140186870Abstract: The application discloses methods, materials, and compositions for the labeling of molecules, for example, proteins, in living cells or in subcellular compartments of living cells. In particular, the application relates to proteomic analysis methods; materials and compositions and means based on direct tagging of unknown proteins with tagging enzymes (such as biotin ligase or a peroxidase) within the vicinity of a tagging substrate (such as a tyramide) within living cells, with optional targeting to specific subcellular locations by expression of genetic constructs.Type: ApplicationFiled: June 15, 2012Publication date: July 3, 2014Applicant: Massachusetts Institute of TechnologyInventors: Alice Y. Ting, Jeffrey Daniel Martell, Hyun-Woo Rhee, Peng Zou
-
Publication number: 20140178917Abstract: A fluidic system that includes at least one channel for the transport of a liquid, the channel being formed of an absorbent material; and at least one switchable polymer gel that functions as a storage reservoir and/or valve for the liquid and is in contact with the absorbent material of the channel.Type: ApplicationFiled: December 19, 2013Publication date: June 26, 2014Applicant: Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.Inventors: Andre Laschewsky, Erik Wishcherhoff, Carsten Beta, Robert Niedl
-
Publication number: 20140170146Abstract: Methods for multiplexed delivery of agents to a solid tissue in vivo followed by assessment of efficacy with mass spectrometry are described.Type: ApplicationFiled: November 13, 2013Publication date: June 19, 2014Applicant: PRESAGE BIOSCIENCES, INC.Inventors: Richard Klinghoffer, Nathan Caffo
-
Publication number: 20140162245Abstract: The present invention relates to methods and compounds for enzyme-mediated amplification of target-associated signals for visualization of biological or chemical targets in samples, wherein the targets are immobilized, in particular the invention relates to the oxidoreductase-mediated signal amplification for visualization of targets in samples comprising cells. The methods of the invention are particular useful for qualitative and quantitative evaluation of biological markers relating to medical diagnostic and therapy.Type: ApplicationFiled: April 19, 2012Publication date: June 12, 2014Inventors: Jesper Lohse, Galina Skladtchikova
-
Publication number: 20140134651Abstract: Disclosed is an analytical composition of a peroxidase discrete polyethylene glycol (PEG) conjugate, which conjugate is capable of providing a detectable condition in the presence of peroxidase and hydrogen peroxide.Type: ApplicationFiled: December 3, 2013Publication date: May 15, 2014Applicant: QUANTA EQIP, LLCInventors: Paul D. Davis, Alexander R. Pokora
-
Patent number: 8703458Abstract: A polymer matrix that may coated on an electrode is created by co-crosslinking (1) an adduct of a polyaniline formed by templated oxidative polymerization on a polymer acid; (2) a water-soluble crosslinker; and (3) a redox enzyme. The polymer matrix may be hydrated, and the absorbed water may make it permeable to, for example, glucose. The polyaniline may be polyaniline itself or a substituted polyaniline; the water-soluble crosslinker may be poly(ethylene glycol) diglycidyl ether, and the redox enzyme may be glucose oxidase. The polymer matrix may be produced by co-crosslinking (1) an adduct of an electrically conductive polymer and a polymer acid; (2) a water-soluble crosslinker; and (3) a redox enzyme in a single step at an about neutral pH, curing by drying. After hydration, the crosslinked polymer matrix may form a 3-dimensional glucose-permeable bioelectrocatalyst, catalyzing the electrooxidation of glucose.Type: GrantFiled: January 31, 2013Date of Patent: April 22, 2014Assignee: Abbott Diabetes Care Inc.Inventors: Adam Heller, Benjamin J. Feldman, Nicolas Mano, Yueh-Lin Loo
-
Patent number: 8703439Abstract: Methods and devices for use in detecting the iodine status of a subject are provided. The methods and devices utilize an iodide binding protein (IBP) to specifically bind to and facilitate detection of iodide in a saliva sample from a subject. The detected iodide can be used to detect the iodide status of the subject. In several examples, the IBP includes an iodide binding domain from a vanadium dependent iodoperoxidase (vIPO), including a catalytically inactive vIPO.Type: GrantFiled: June 14, 2012Date of Patent: April 22, 2014Inventor: Linda Lester
-
Patent number: 8691194Abstract: Methods of producing lignin peroxidase are provided. Also provided are methods and cosmetic compositions suitable for skin and hair lightening as well as kits and an article-of manufacturing including active ingredients for skin and hair lightening.Type: GrantFiled: May 27, 2008Date of Patent: April 8, 2014Assignee: R.B.T (Rakuto Bio Technologies) Ltd.Inventors: Paula Belinky, Haim Lasser, Carlos Dosoretz
-
Publication number: 20140093895Abstract: A test strip to assist in determining the concentration of an analyte in a fluid sample comprises a base, at least one tab and a break line. The base includes a capillary channel and a test element. The capillary channel is in fluid communication with the test element. The test element is adapted to receive the fluid sample. The at least one tab is removably attached to the base. The capillary channel extends from the base into a portion of the tab. The break line intersects the capillary channel in which an inlet to the capillary channel is exposed along the break line when the tab is separated from the base.Type: ApplicationFiled: December 4, 2013Publication date: April 3, 2014Applicant: Bayer HealthCare LLCInventor: Roger Fleming
-
Publication number: 20140065653Abstract: High-density microfluidic chips contain plumbing networks with thousands of micromechanical valves and hundreds of individually addressable chambers. These fluidic devices are analogous to electronic integrated circuits fabricated using large scale integration (LSI). A component of these networks is the fluidic multiplexor, which is a combinatorial array of binary valve patterns that exponentially increases the processing power of a network by allowing complex fluid manipulations with a minimal number of inputs. These integrated microfluidic networks can be used to construct a variety of highly complex microfluidic devices, for example the microfluidic analog of a comparator array, and a microfluidic memory storage device resembling electronic random access memories.Type: ApplicationFiled: November 16, 2012Publication date: March 6, 2014Applicant: California Institute of TechnologyInventor: California Institute of Technology
-
Publication number: 20140057255Abstract: Systems and methods are provided for collecting, preparing, and/or analyzing a biological sample. A sample collection site may be utilized with one or more sample processing device. The sample processing device may be configured to accept a sample from a subject. The sample processing device may perform one or more sample preparation step and/or chemical reaction involving the sample. Data related to the sample may be sent from the device to a laboratory. The laboratory may be a certified laboratory that may generate a report that is transmitted to a health care professional. The health care professional may rely on the report for diagnosing, treating, and/or preventing a disease in the subject.Type: ApplicationFiled: February 18, 2013Publication date: February 27, 2014Applicant: Theranos, Inc.Inventor: Elizabeth A. Holmes
-
Patent number: 8658361Abstract: Disclosed is a method for in situ detection of one or more target nucleic acids based on a combination of an in situ hybridization (ISH) assay method and a general ISH signal amplification method. This new method produces high signal intensity and while keeps low background noise of signal amplification. The result can be consistently reproduced and the method can be easily adopted for routine clinic diagnostic use. Further, the invention relates to a kit, comprising the components of the ISH assay and a general ISH signal amplification assay, for sensitive detection of one or more target nucleic acids.Type: GrantFiled: October 21, 2011Date of Patent: February 25, 2014Assignee: Advanced Cell Diagnostics, Inc.Inventors: Xingyong Wu, Huei-Yu Fay Wang, Nan Su, Li-Chong Wang, Yuling Luo
-
Publication number: 20130337481Abstract: The invention provides an assay method for determining a level of haptoglobin in a sample comprising the steps of: (i) mixing haemoglobin with the sample to be assayed so as to form a haptoglobin-haemoglobin complex with haptoglobin present in the sample; (ii) contacting the product of step (i) with reagents for generating hydrogen peroxide and one or more chromogens which undergo a spectroscopically detectable change when peroxidase activity is present, in the presence of a buffer, under conditions in which hydrogen peroxide is generated from said reagents and forms a substrate for the peroxidise activity of the haptoglobin-haemoglobin complex present, and wherein the pH of the buffer is within a range which is sufficiently low that the peroxidise activity of any uncomplexed haemoglobin is substantially suppressed but sufficiently high that hydrogen peroxide generation occurs; (iii) determining the peroxidase activity of the haptoglobin-haemoglobin complex by measuring the change in an optical property of thType: ApplicationFiled: December 19, 2011Publication date: December 19, 2013Applicant: REACTIVLAB LIMITEDInventors: Peter David Eckersall, Ellidh McCulloch, Stuart Docherty
-
Patent number: 8609349Abstract: The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.Type: GrantFiled: April 4, 2012Date of Patent: December 17, 2013Assignee: Nestec S.A.Inventors: Sharat Singh, Jeanne Harvey, Phillip Kim, Xinjun Liu, Limin Liu, Robert Barham, Bruce Neri
-
Patent number: 8603765Abstract: The present invention provide reagents and methods of using the reagents, for example, on automated staining devices, that facilitate detection of two or more antigens in a sample simply and efficiently.Type: GrantFiled: October 27, 2009Date of Patent: December 10, 2013Assignee: Biocare Medical, LLC.Inventor: David Tacha
-
Publication number: 20130316386Abstract: According to one embodiment, a test element includes a base, a pair of optical element units, an optical waveguide unit, a detection unit and a holding unit. The base has transparency. The pair of optical element units are arranged away from each other on a major surface of the base. The optical waveguide unit is provided on the major surface of the base. The detection unit is provided on a major surface of the optical waveguide unit of between the optical element units. The major surface of the optical waveguide unit is an opposite side which touches the base. The holding unit is in a frame shape, and one end of the holding unit being is provided to protrude from a major surface of the detection unit. The detection unit includes a color former and a film-formed body holding the color former.Type: ApplicationFiled: August 1, 2013Publication date: November 28, 2013Applicant: Kabushiki Kaisha ToshibaInventors: Ichiro Tono, Takaaki Wada, Kayoko Oomiya, Shingo Kasai, Masaaki Hirakawa
-
Publication number: 20130302841Abstract: The present invention relates to the determination of the level of marker peptides in a sample derived from a bodily fluid of a subject presenting to the emergency department with non-specific complaints.Type: ApplicationFiled: October 31, 2011Publication date: November 14, 2013Applicant: B.R.A.H.M.S GMBHInventors: Joachim Struck, Sven Giersdorf, Oliver Hartmann, Roland Bingisser, Christian Nickel
-
Publication number: 20130288283Abstract: The present invention provides a method for measuring a component to be measured in a sample, comprising converting the component to be measured in the sample into hydrogen peroxide and measuring the formed hydrogen peroxide in the presence of an ?-keto acid using an oxidative-coloring chromogen. The present invention also provides a method for suppressing the influence of a peroxide on a method of converting a component to be measured in a sample into hydrogen peroxide and measuring the formed hydrogen peroxide using an oxidative-coloring chromogen, the suppression method comprising using an ?-keto acid. The measuring method and the suppression method of the present invention using an ?-keto acid suppress the influence of a peroxide to give an accurate measurement of the component to be measured in the sample.Type: ApplicationFiled: December 12, 2011Publication date: October 31, 2013Applicant: KYOWA MEDEX CO., LTD.Inventor: Tomomi Murakami
-
Publication number: 20130261067Abstract: The invention provides methods for production of gangliosides, e.g., GM1, from cells in culture using, for example, bone marrow cells and neuroblastoma cells. Methods include the treatment of cells with neural induction media and chloroquine, or chloroquine alone in the case of, e.g., human bone marrow cells, neuraminidase or glucosamine, to induce the production of gangliosides, e.g., GM1, in the cells. Also provided are methods of long-term, high density culturing of cells without passaging to produce gangliosides, e.g., GM1. Methods of quantifying gangliosides, e.g., GM1 in cell culture are also provided.Type: ApplicationFiled: March 12, 2013Publication date: October 3, 2013Inventors: Vanessa RAGAGLIA, Vandana Madanlal Sharma
-
Publication number: 20130252261Abstract: The invention provides compositions, kits, and methods for performing colorimetric analysis. A substrate is reacted to generate a chromogenic reaction product, and a reaction stop reagent that is a sulfonic acid is added to stop and stabilize the reaction product. The absorbance properties of the chromogenic reaction product can be maintained over significantly longer periods of time of that of conventional reagents and methods. The sulfonic acid can be used in assays such as ELISAs in order to provide a more accurate and safer detection of analytes in a biological sample.Type: ApplicationFiled: March 22, 2013Publication date: September 26, 2013Inventors: Gary Opperman, Wendy Nelson
-
Publication number: 20130203100Abstract: A specimen processing system is capable of processing specimens carried on slides. The specimen processing system can sequentially deliver slides and opposables to specimen processing stations. The specimen processing stations can use the opposables to apply a series of liquids to the specimens. The applied liquid can be moved along the slide using capillary action while the specimen processing stations control the processing temperatures. The applied liquid can be in a fluid-carrying gap. The opposable can contact the slide to vary a cross section of the fluid-carrying gap.Type: ApplicationFiled: March 14, 2013Publication date: August 8, 2013Applicant: VENTANA MEDICAL SYSTEMS, INC.Inventor: VENTANA MEDICAL SYSTEMS, INC.
-
Publication number: 20130196360Abstract: A microfluidic device and control method thereof are provided. The control method of the microfluidic device includes detecting a background signal from a chamber in which a reaction product formed by combining an analyte and a marking material is not accommodated, detecting a detection signal from a chamber in which the reaction product is accommodated, and compensating for the detection signal using the background signal.Type: ApplicationFiled: January 25, 2013Publication date: August 1, 2013Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventor: Samsung Electronics Co., Ltd.
-
Patent number: 8486657Abstract: It is disclosed herein that antibodies specific for preproproteins or preproteins, which are synthesized by certain types of cells or tissues, can be used in immunohistochemistry assays to discriminate between the intracellular component of the protein (including the preproprotein, preprotein and/or proprotein forms of the protein) from the secreted component of the same protein. Accordingly, provided herein is an immunohistochemical method for specific detection of the intracellular form of a protein in a biological sample using an antibody specific for the preproprotein or preprotein form of the protein. In particular examples, the protein is albumin or an immunoglobulin light chain. Also disclosed herein are preproprotein-specific ore preprotein-specific antibodies that can be used to detect specific cell types, tissue lesions or other pathological foci and metastases by IHC. In particular, antibodies that specifically bind human preproalbumin, but do not bind the secreted form of albumin are disclosed.Type: GrantFiled: March 22, 2010Date of Patent: July 16, 2013Inventors: Xiaohong Cai, Thomas Cai
-
Publication number: 20130131146Abstract: The present invention relates to the role of cystic fibrosis transmembrane conductance regulator (CFTR) in pulmonary conditions. In one embodiment, a method for assessing the severity of lung damage from a pulmonary condition in a subject comprises the steps of (a) measuring the level and/or functional activity of membrane/lipid-raft cystic fibrosis transmembrane conductance regulator (CFTR)in a sample from the subject; (b) measuring the level of ceramide or its species in a sample from the subject; and (c) comparing the membrane/lipid- raft CFTR level and/or functional activity and ceramide level to a control sample, wherein a difference in membrane/lipid-raft CFTR level and/or functional activity and ceramide level is indicative of the severity of lung damage. The method can further comprise treating the subject based on the severity of lung damage. In particular embodiments, the treatment comprises administering a CFTR agonist and/or an agent that inhibits the synthesis of ccramide or its species.Type: ApplicationFiled: May 2, 2011Publication date: May 23, 2013Applicant: THE JOHNS HOPKINS UNIVERSITYInventors: Neeraj Vij, Manish Bodas
-
Publication number: 20130122533Abstract: A method is provided for preparing electrically conductive polymer and cellulose nanocomposite particles and nanocomposite materials. Cellulose microparticles coated with a conductive polymer are added to an acid solution for initiating an acid hydrolysis reaction for a prescribed time interval to form conductive polymer coated cellulose nanoparticles. After quenching the acid hydrolysis reaction, the nanoparticles are separated to obtain a colloidal solution of conductive nanoparticles. The conductive nanoparticles may be subsequently formed into a solid nanocomposite material such as a conductive film. Transparent conductive films may be prepared by forming thin layers having a thickness on a micron or submicron scale.Type: ApplicationFiled: May 12, 2011Publication date: May 16, 2013Applicant: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTOInventors: Syed Abthagir Pitchai-Mydeen, Ning Yan
-
Publication number: 20130122518Abstract: A panel for monitoring levels of biomarkers, including an assay having at least one inflammation monitoring test, at least one oxidative stress monitoring test, and at least one antioxidant activity monitoring test. A method of monitoring an individual's health, by collecting a sample from the individual, applying the sample to an assay panel, performing at least one inflammation monitoring test, at least one oxidative stress monitoring test, and at least one antioxidant activity monitoring test in the panel, and determining levels of biomarkers related to inflammation, oxidative stress, and antioxidant activity and therefore providing information regarding the individual's relative health and/or risk of developing one or more diseases.Type: ApplicationFiled: July 21, 2011Publication date: May 16, 2013Applicant: WELLNESS INDICATORS, INC.Inventors: Denis M. Callewaert, Andrew A. Dahl
-
Publication number: 20130116293Abstract: Described herein are high-throughput methods of monitoring D-serine levels in plasma. The assay involves the use of strong cation solid phase extraction (SPE) to isolate D-serine from plasma, followed by quantitation of D-serine using the D-amino acid oxidase-(DAAO-) catalyzed reaction. Also described are methods of screening for compounds that act as DAAO inhibitors.Type: ApplicationFiled: November 8, 2012Publication date: May 9, 2013Applicant: THE JOHNS HOPKINS UNIVERSITYInventor: THE JOHNS HOPKINS UNIVERSITY
-
Publication number: 20130109019Abstract: Embodiments of hapten conjugates including a hapten, an optional linker, and a peroxidase-activatable aryl moiety are disclosed. In some embodiments, the peroxidase-activatable aryl moiety is tyramine or a tyramine derivative. Embodiments of methods for making and using the hapten conjugates also are disclosed. In particular embodiments, the hapten conjugates are used in a signal amplification assay. In certain embodiments, the hapten is an oxazole, a pyrazole, a thiazole, a benzofurazan, a triterpene, a urea, a thiourea other than a rhodamine thiourea, a nitroaryl other than dinitrophenyl or trinitrophenyl, a rotenoid, a cyclolignan, a heterobiaryl, an azoaryl, a benzodiazepine, or 7-diethylamino-3-carboxycoumarin. The hapten is coupled to the peroxidase-activatable aryl moiety directly or indirectly via a linker. In certain embodiments, the hapten conjugates are used in multiplexed assays.Type: ApplicationFiled: July 1, 2011Publication date: May 2, 2013Inventors: Adrian E. Murillo, Jerome W. Kosmeder, Eric May, William Day, Mark Lefever, Anne M. Pedata, Christopher Bieniarz, Phillip Miller
-
Publication number: 20130109038Abstract: Provided are an analytical instrument and an analytical method that allow for the direct analysis of a target substance in an undiluted specimen by a transmission photometry in a tightly closed cell container space. An analytical instrument is an analytical instrument for analyzing a target substance contained in a specimen flown in the tightly closed cell container by utilizing an oxidative color-developing agent and an oxidative enzyme reaction, in which an upper substrate and a lower substrate are arranged facing each other and at least a part of the upper substrate and/or at least a part of the lower substrate are/is made of a material transmitting light used for the analysis and having oxygen transmission properties.Type: ApplicationFiled: October 12, 2012Publication date: May 2, 2013Applicant: ARKRAY, INC.Inventor: ARKRAY, INC.
-
Publication number: 20130102019Abstract: Methods for characterizing the near term risk of experiencing a major adverse cardiac event in a patient presenting with chest pain are provided. In one embodiment the method comprises determining the level of myeloperoxidase (MPO) activity in a bodily sample obtained from the patient. In another embodiment, the method comprises determining the level of MPO mass in a bodily sample obtained from the patient. In another embodiment, the method comprises determining the level of one or more select MPO-generated oxidation products in a bodily sample obtained from the patient. The select MPO-generated oxidation products are dityrosine, nitrotyrosine, chlorotyrosine, methionine sulphoxide or an MPO-generated lipid peroxidation product.Type: ApplicationFiled: December 7, 2012Publication date: April 25, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventors: Stanley L. Hazen, Renliang Zhang
-
Publication number: 20130102014Abstract: The invention provides novel fluorinated resorufin compounds that are of use in a variety of assay formats. Also provided are methods of using the compounds and kits that include a compound of the invention and instructions detailing the use of the compound in one or more assay formats.Type: ApplicationFiled: September 12, 2012Publication date: April 25, 2013Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Robert Harley Batchelor, Yue Ge, Iain D. Johnson, Wai-Yee Leung, Jixiang Liu, Brian Patch, Peter Smalley, Thomas Steinberg
-
Patent number: 8426159Abstract: A chemostat is described that includes a growth chamber having a plurality of compartments. Each of the compartments may be fluidly isolated from the rest of the growth chamber by one or more actuatable valves. The chemostat may also include a nutrient supply-line to supply growth medium to the growth chamber, and an output port to remove fluids from the growth chamber. Also, a method of preventing biofilm formation in a growth chamber of a chemostat is described. The method may include the steps of adding a lysis agent to a isolated portion of the growth chamber, and reuniting the isolated portion with the rest of the growth chamber.Type: GrantFiled: August 3, 2011Date of Patent: April 23, 2013Assignee: California Institute of TechnologyInventors: Frederick Balagadde, Carl L. Hansen, Emil Kartalov, Stephen R. Quake
-
Patent number: 8426213Abstract: The present invention relates to providing improved hydrogen peroxide assays, as well as droplet actuators for conducting such assays. The droplet actuators of the invention may be used to conduct droplet-based hydrogen peroxide assays. They may also be associated with detectors for analyzing the results of the hydrogen peroxide assays of the invention. They may be provided as components of systems which control droplet operations and/or detection for conducting the hydrogen peroxide assays. Measurement by the detector may be used to quantify the presence of an analyte in a sample.Type: GrantFiled: March 5, 2008Date of Patent: April 23, 2013Assignee: Advanced Liquid Logic IncInventors: Allen E. Eckhardt, Vijay Srinivasan, Vamsee K. Pamula
-
Publication number: 20130078664Abstract: The invention provides enzymatic methods for direct determination of percentage of glycated hemoglobin in blood samples without the need of a separated measurement of total hemoglobin content in blood samples. The methods utilizes one or two different types of oxidizing agents which selectively oxidize low-molecular weight reducing substances and high-molecular weight (mainly hemoglobin) reducing substances in blood samples, coupled with enzymatic reactions catalyzed by proteases, fructosyl amino acid oxidase. The amount of hydrogen peroxide generated in the reaction is measured for determination of percentage of glycated hemoglobin in blood samples. The invention provides kits for performing the methods of the invention.Type: ApplicationFiled: November 9, 2012Publication date: March 28, 2013Applicant: GENERAL ATOMICSInventor: General Atomics
-
Publication number: 20130078624Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.Type: ApplicationFiled: September 26, 2011Publication date: March 28, 2013Applicant: Theranos, Inc., a Delaware CorporationInventors: Elizabeth Holmes, Sunny Balwani
-
Publication number: 20130078663Abstract: Pore-limit electrophoresis (PLE) microchannel assay methods are provided. Aspects of the methods include sequentially introducing samples at least suspected of containing first and second assay members into a PLE microchannel and then evaluating the microchannel for interaction between the first and second assay members. Aspects of the invention further include devices, systems and kits configured for practicing methods of invention. The methods, devices, systems and kits of the invention find use in a variety of different applications, including enzyme activity assays and immunoassays.Type: ApplicationFiled: December 1, 2010Publication date: March 28, 2013Inventors: Amy E. Herr, Xiofang Chen